Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes.
Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report.
Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?
Use of antiviral drugs to reduce COVID-19 transmission.
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing.
New emerging targets in cancer immunotherapy: the role of neoantigens.
Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema.